Cargando…

Expected impact of MRI-related interreader variability on ProScreen prostate cancer screening trial: a pre-trial validation study

BACKGROUND: The aim of this study is to investigate the potential impact of prostate magnetic resonance imaging (MRI) -related interreader variability on a population-based randomized prostate cancer screening trial (ProScreen). METHODS: From January 2014 to January 2018, 100 men aged 50–63 years wi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hietikko, Ronja, Kilpeläinen, Tuomas P., Kenttämies, Anu, Ronkainen, Johanna, Ijäs, Kirsty, Lind, Kati, Marjasuo, Suvi, Oksala, Juha, Oksanen, Outi, Saarinen, Tuomas, Savolainen, Ritja, Taari, Kimmo, Tammela, Teuvo L. J., Mirtti, Tuomas, Natunen, Kari, Auvinen, Anssi, Rannikko, Antti
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7547469/ https://www.ncbi.nlm.nih.gov/pubmed/33036660 http://dx.doi.org/10.1186/s40644-020-00351-w

Ejemplares similares

Population‐based randomized trial of screening for clinically significant prostate cancer ProScreen: a pilot study
por: Rannikko, Antti, et al.
Publicado: (2022)

Prostate MRI added to CAPRA, MSKCC and Partin cancer nomograms significantly enhances the prediction of adverse findings and biochemical recurrence after radical prostatectomy
por: Sandeman, Kevin, et al.
Publicado: (2020)

Repeat multiparametric MRI in prostate cancer patients on active surveillance
por: Eineluoto, Juho T., et al.
Publicado: (2017)

Non-Steroidal Anti-Inflammatory Drugs and Cancer Death in the Finnish Prostate Cancer Screening Trial
por: Veitonmäki, Thea, et al.
Publicado: (2016)

Digoxin and prostate cancer survival in the Finnish Randomized Study of Screening for Prostate Cancer
por: Kaapu, Kalle J, et al.
Publicado: (2016)

Prostate cancer-specific survival among warfarin users in the Finnish Randomized Study of Screening for Prostate Cancer
por: Kinnunen, Pete T. T., et al.
Publicado: (2017)

Fasting blood glucose, glycaemic control and prostate cancer risk in the Finnish Randomized Study of Screening for Prostate Cancer
por: Murtola, Teemu J., et al.
Publicado: (2018)

Prostate cancer incidence in men with prostate‐specific antigen below 3 ng/mL: The Finnish Randomized Study of Screening for Prostate Cancer
por: Ola, Idris Olasunmbo, et al.
Publicado: (2022)

Long‐term health‐related quality of life among men with prostate cancer in the Finnish randomized study of screening for prostate cancer
por: Talala, Kirsi, et al.
Publicado: (2020)

Cost-effectiveness analysis of PSA-based mass screening: Evidence from a randomised controlled trial combined with register data
por: Booth, Neill, et al.
Publicado: (2019)

Prognostic Index for Predicting Prostate Cancer Survival in a Randomized Screening Trial: Development and Validation
por: Neupane, Subas, et al.
Publicado: (2021)

Genotyped functional screening of soluble Fab clones enables in-depth analysis of mutation effects
por: Oksanen, Sami, et al.
Publicado: (2023)

Anti-epileptic drugs and prostate cancer-specific mortality compared to non-users of anti-epileptic drugs in the Finnish Randomized Study of Screening for Prostate Cancer
por: Salminen, Jukka K., et al.
Publicado: (2022)

Prostate cancer risk prediction using a polygenic risk score
por: Sipeky, Csilla, et al.
Publicado: (2020)

Antihypertensive drug use and prostate cancer-specific mortality in Finnish men
por: Siltari, Aino, et al.
Publicado: (2020)

Charlson Comorbidity Index Based On Hospital Episode Statistics Performs Adequately In Predicting Mortality, But Its Discriminative Ability Diminishes Over Time
por: Pylväläinen, Juho, et al.
Publicado: (2019)

Inverse Association between Statin Use and Cancer Mortality Relates to Cholesterol Level
por: Peltomaa, Antti I., et al.
Publicado: (2022)

Spectral decoupling for training transferable neural networks in medical imaging
por: Pohjonen, Joona, et al.
Publicado: (2022)

AI Model for Prostate Biopsies Predicts Cancer Survival
por: Sandeman, Kevin, et al.
Publicado: (2022)

Stromal FAP Expression is Associated with MRI Visibility and Patient Survival in Prostate Cancer
por: Pellinen, Teijo, et al.
Publicado: (2022)

Cancer mortality does not differ by antiarrhythmic drug use: A population-based cohort of Finnish men
por: Kaapu, Kalle J., et al.
Publicado: (2018)

Differential Predictive Roles of A- and B-Type Nuclear Lamins in Prostate Cancer Progression
por: Saarinen, Irena, et al.
Publicado: (2015)

Fibroblast as a critical stromal cell type determining prognosis in prostate cancer
por: Blom, Sami, et al.
Publicado: (2019)

Novel prostate cancer susceptibility gene SP6 predisposes patients to aggressive disease
por: Sipeky, Csilla, et al.
Publicado: (2021)

Outcomes of prostate cancer screening among men using antidiabetic medication
por: Vettenranta, A., et al.
Publicado: (2021)

Prostate cancer risk and nonsteroidal antiinflammatory drug use in the Finnish prostate cancer screening trial
por: Veitonmäki, T, et al.
Publicado: (2014)

Reducing overdiagnosis by polygenic risk-stratified screening: findings from the Finnish section of the ERSPC
por: Pashayan, Nora, et al.
Publicado: (2015)

Exploration of Extracellular Vesicle miRNAs, Targeted mRNAs and Pathways in Prostate Cancer: Relation to Disease Status and Progression
por: Puhka, Maija, et al.
Publicado: (2022)

False-positive screening results in the Finnish prostate cancer screening trial
por: Kilpeläinen, T P, et al.
Publicado: (2010)

Investigating Tumor Heterogeneity in Mouse Models
por: Tammela, Tuomas, et al.
Publicado: (2019)

European randomized study of prostate cancer screening: first-year results of the Finnish trial
por: Määttänen, L, et al.
Publicado: (1999)

Missingness in the expanded prostate cancer index short form (EPIC-26) – prevalence, patterns, and explanatory factors
por: Talvitie, Anna-Maija, et al.
Publicado: (2023)

Grading Evolution and Contemporary Prognostic Biomarkers of Clinically Significant Prostate Cancer
por: Sopyllo, Konrad, et al.
Publicado: (2021)

Power electronic converters: dynamics and control in conventional and renewable energy applications
por: Suntio, Teuvo, et al.
Publicado: (2018)

Editorial: With obesity becoming the new normal, what should we do? ‐Volume II
por: Tziomalos, Konstantinos, et al.
Publicado: (2022)

Prostate cancer screening: what can we learn from randomised trials?
por: Auvinen, Anssi
Publicado: (2018)

Improvement of Fab expression by screening combinatorial synonymous signal sequence libraries
por: Kulmala, Antti, et al.
Publicado: (2019)

Is the Prevalence of Overactive Bladder Overestimated? A Population-Based Study in Finland
por: Tikkinen, Kari A.O., et al.
Publicado: (2007)

Intervention-related Deaths in the European Randomized Study of Screening for Prostate Cancer
por: Godtman, Rebecka Arnsrud, et al.
Publicado: (2021)

Active surveillance versus initial surgery in the long-term management of Bosniak IIF–IV cystic renal masses
por: Luomala, Lassi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8hhojhpeg3kqnukjctutv41cmn